Document Detail


Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
MedLine Citation:
PMID:  7537249     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The competitive binding specificities of glucuronoxylomannan (GXM) and its derivatives to factor sera of Cryptococcus neoformans were studied by enzyme-linked immunosorbent assay. An effort was made to determine the epitope specificity of each factor serum. Despite the presence of antigenic factor 1 on all serotypes of C. neoformans, variations in inhibition ability were observed with different GXMs. The panspecific component of factor serum 1 (antibody 1) appeared to be due to the presence of more than one antibody component. The activity was dependent on the 6-O-acetyl substituent. GXMs of serotypes A and D inhibited factor serum 2 equally well, indicating a low titer for the antibody 7 component. Serotype B GXM was a poor inhibitor, and serotype C GXM did not inhibit factor serum 2. The activity of factor serum 2 was 6-O-acetyl dependent. GXMs from typical serotype A and serotype D isolates were excellent inhibitors of factor serum 3. GXMs from serotype B were poorly inhibitory and serotype C did not inhibit factor serum 3. The activity of factor serum 3 was 6-O-acetyl dependent. The activity of factor serum 4 was due predominantly to antibody component 6. The activity of factor 4 was directed mainly against serotype C, and it was independent of 6-O-acetyl substitution Factor serum 5 was specific for serotype B GXMs. The inhibitory effect was independent of 6-O-acetyl substitution, but the effect was diminished by reduction of the glucuronic acid. The GXMs with a typical serotype C structure inhibited antibody 6. O deacetylation of the GXMs did not affect their inhibitory activity. However, reduction of glucuronic acid reduced factor serum 6 binding. Factor serum 8 was specific to serotype D; native GXMs of serotype A were slightly inhibitory. O deacetylation of the serotype D GXMs abrogated the inhibitory effect. O deacetylation alone abrogates the activity of antibody components 1, 2, 3, and 8. Reduction of glucuronic acid reduces the inhibitory activity of the GXM to antibody components 4, 5, and 6. Partial GXM structures and methyl glycosides did not effectively inhibit the activity of any of the factor sera.
Authors:
T Belay; R Cherniak
Related Documents :
17673279 - A case study of real-world tailpipe emissions for school buses using a 20% biodiesel bl...
7351349 - The nature of secretory agglutinins and aggregating factors. ii. biochemical and immuno...
6798569 - Monoclonal antibodies against human factor viii molecular neutralize antihemophilic fac...
6773169 - In vivo characteristics of thaw siphon cryoprecipitate compared to other factor viii pr...
19114189 - Formation of anti-platelet factor 4/heparin antibodies after cardiac surgery: influence...
22908309 - T granules in human platelets function in tlr9 organization and signaling.
6942559 - Ultrastructural alterations of megakaryocytes in some hematologic disorders.
8400419 - An in vitro method for assessing the effects of pro-inflammatory and anti-inflammatory ...
12590949 - Theonezolide a, a novel marine macrolide, induces drastic shape change in rabbit platel...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Infection and immunity     Volume:  63     ISSN:  0019-9567     ISO Abbreviation:  Infect. Immun.     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-06-01     Completed Date:  1995-06-01     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0246127     Medline TA:  Infect Immun     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1810-9     Citation Subset:  IM    
Affiliation:
Department of Chemistry, Georgia State University, Atlanta 30303, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibodies, Fungal / classification,  immunology*
Antibody Specificity
Antigens, Fungal / immunology
Binding, Competitive
Carbohydrate Sequence
Cryptococcus neoformans / immunology*
Enzyme-Linked Immunosorbent Assay / methods*
Epitopes / immunology
Humans
Molecular Sequence Data
Polysaccharides / immunology*
Rabbits
Serotyping / methods*
Grant Support
ID/Acronym/Agency:
AI-31769/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Antibodies, Fungal; 0/Antigens, Fungal; 0/Epitopes; 0/Polysaccharides; 76082-65-0/glucuronoxylomannan
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes.
Next Document:  Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macr...